Shivbrat Upadhyay
Research Subjects
Research Interests
Shivbrat Upadhyay has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aditi Srivastava
Department of Biochemistry, Era's Lucknow Medical College & Hospital, Era University, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India
2 shared publications - Ishrat Husain
Department of Biochemistry, Era's Lucknow Medical College & Hospital, Era University, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India
2 shared publications - Rumana Ahmad
Department of Biochemistry, Era's Lucknow Medical College & Hospital, Era University, Sarfarazganj, Lucknow, UP 226003, India
2 shared publications - Anamika Gupta
Sharjah Institute for Medical Sciences University of Sharjah Sharjah United Arab Emirates
1 shared publication - Anchal Trivedi
Department of Biochemistry, Era's Lucknow Medical College and Hospital Era University Lucknow Uttar Pradesh India
1 shared publication - Bilal Ahmad
Research Cell, Era’s Lucknow Medical College and Hospital, Era University, Lucknow, Uttar Pradesh, India
1 shared publication
Latest Publications
- 21 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103708
Evaluation of dose and time-dependent effects of methyl butyrate, a major essential oil component, on cancer cell survival in vitro
- 21 June 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103708
Evaluation of dose and time-dependent effects of methyl butyrate, a major essential oil component, on cancer cell survival in vitro
- 8 December 2020
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (9) , 3928-3948
Virtual screening of phytoconstituents from miracle herbnigella sativatargeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel etiological agent of coronavirus disease 2019 (COVID-19). Nigella sativa, commonly known as black seed or black cumin, has been a historical and traditional plant since thousands of years. Based on their therapeutic efficacy, the chief components of terpenoids and flavonoids were selected from N. sativa seeds and seed oil. This study was designed to check the antiviral efficacy of N. sativa main phytoconstituents against five potential targets of SARS-CoV-2 using in silico structure-based virtual screening approach. Out of twenty five phytocomponents, ten components showed best binding affinity against two viral proteins viz. N-terminal RNA binding domain (NRBD; PDB ID: 6M3M) of nucleocapsid protein and papain-like protease (PL-PRO; PDB ID: 6W9C) of SARS-CoV-2 using AutoDock 4.2.6, AutoDock Vina and iGEMDOCK. PASS analyses of all ten phytocomponents using Lipinski’s Rule of five showed promising results. Further, druglikeness and toxicity assessment using OSIRIS Data Warrior v5.2.1 software exhibited the feasibility of phytocomponents as drug candidates with no predicted toxicity. Molecular dynamics simulation study of NRBD of SARS-CoV-2 nucleocapsid protein-alpha-spinasterol complex and PL-PRO-cycloeucalenol complex displayed strong stability at 300 K. Both these complexes exhibited constant root mean square deviation (RMSDs) of protein side chains and Cα atoms throughout the simulation run time. Interestingly, PL-PRO and NRBD are key proteins in viral replication, host cell immune evasion and viral assembly. Thus, NRBD and PL-PRO have the potential to serve as therapeutic targets for N. sativa phytoconstituents in drug discovery process against COVID-19. Graphical Abstract Communicated by Ramaswamy H. Sarma
- 8 December 2020
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (9) , 3928-3948
Virtual screening of phytoconstituents from miracle herbnigella sativatargeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel etiological agent of coronavirus disease 2019 (COVID-19). Nigella sativa, commonly known as black seed or black cumin, has been a historical and traditional plant since thousands of years. Based on their therapeutic efficacy, the chief components of terpenoids and flavonoids were selected from N. sativa seeds and seed oil. This study was designed to check the antiviral efficacy of N. sativa main phytoconstituents against five potential targets of SARS-CoV-2 using in silico structure-based virtual screening approach. Out of twenty five phytocomponents, ten components showed best binding affinity against two viral proteins viz. N-terminal RNA binding domain (NRBD; PDB ID: 6M3M) of nucleocapsid protein and papain-like protease (PL-PRO; PDB ID: 6W9C) of SARS-CoV-2 using AutoDock 4.2.6, AutoDock Vina and iGEMDOCK. PASS analyses of all ten phytocomponents using Lipinski’s Rule of five showed promising results. Further, druglikeness and toxicity assessment using OSIRIS Data Warrior v5.2.1 software exhibited the feasibility of phytocomponents as drug candidates with no predicted toxicity. Molecular dynamics simulation study of NRBD of SARS-CoV-2 nucleocapsid protein-alpha-spinasterol complex and PL-PRO-cycloeucalenol complex displayed strong stability at 300 K. Both these complexes exhibited constant root mean square deviation (RMSDs) of protein side chains and Cα atoms throughout the simulation run time. Interestingly, PL-PRO and NRBD are key proteins in viral replication, host cell immune evasion and viral assembly. Thus, NRBD and PL-PRO have the potential to serve as therapeutic targets for N. sativa phytoconstituents in drug discovery process against COVID-19. Graphical Abstract Communicated by Ramaswamy H. Sarma
- 1 January 2020
- Published by Elsevier
- p. 159-181
Proteases: an unexplored enzyme for biomass conversion